SUBSCRIBE
SUBSCRIBE

Vertex Pharmaceuticals

NEWS
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Booming Alnylam to Take Over Vertex’s Large Space in Cambridge
April 6, 2015
 · 
2 min read
Drug Development
Why Investors Shouldn’t Freak Out Over Vertex’s Latest Trial Results
March 24, 2015
 · 
1 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Genetown
Poll Finds Massive Support for Boston Biotech After Vertex Move
March 19, 2015
 · 
1 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Here’s Why Investors are Already Anticipating Vertex Trial Data Coming This Month
March 16, 2015
 · 
2 min read
Why Booming Vertex is on Its Way to Becoming Gilead's Mini-Me
Business
Vertex Terminates Leases on Three Properties in Cambridge, Massachusetts
March 2, 2015
 · 
2 min read
Genetown
Vertex Pharmaceuticals (MA) Learns From Gilead Sciences, Inc.'s Solvadi Mistakes as it Preps for CF Drug Launch
February 2, 2015
 · 
1 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Genetown
Vertex Pharmaceuticals (MA)'s CEO Believes Obama’s $215 Million Plan Would Mean Better New Drugs
February 2, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Genetown
Vertex Pharmaceuticals (MA)'s R&D Chief to Meet With Obama Today
January 30, 2015
 · 
3 min read
Business
Renowned Geneticist Altshuler Ditches The Broad Institute For Vertex Pharmaceuticals (MA)
December 15, 2014
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2023 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Genetown
Vertex Pharmaceuticals (MA) To Present At The RBC Global Healthcare Conference On February 25
February 21, 2014
 · 
1 min read
Business
Governor Patrick And The Massachusetts Life Sciences Center Celebrate The Opening Of The New Vertex Pharmaceuticals (MA) Facility In Boston
February 4, 2014
 · 
3 min read
Business
Vertex Pharmaceuticals (MA) Reports Full-Year And Fourth Quarter 2013 Financial Results And Provides Financial Guidance For 2014
January 30, 2014
 · 
1 min read
Drug Development
Vertex Pharmaceuticals (MA) Announces Sustained Viral Response Rate (SVR4) Data From All-Oral Study Of VX-135 In Combination With Daclatasvir In Hepatitis C
January 9, 2014
 · 
1 min read
Business
Vertex Pharmaceuticals (MA) Announces Upcoming Presentation At J.P. Morgan Healthcare Conference And Date Of Fourth Quarter And Full Year 2013 Financial Results
January 8, 2014
 · 
1 min read
Drug Development
Vertex Pharmaceuticals (MA)'s Cystic Fibrosis Drug Ivacaftor Misses Goal In Late-Stage Study But Helps Some Adults
December 19, 2013
 · 
13 min read
Deals
Vertex Pharmaceuticals (MA) Unloads INCIVO® Product Royalty Rights For $152 Million
November 20, 2013
 · 
5 min read
Job Trends
Vertex Pharmaceuticals (MA) Slashes 370 Jobs as Hep C Drug Sales Plunge
October 29, 2013
 · 
1 min read
Business
Vertex Pharmaceuticals (MA) Reports Third Quarter 2013 Financial Results and Provides Financial Outlook for 2014
October 29, 2013
 · 
1 min read
Drug Development
Vertex Pharmaceuticals (MA)'s VX-509 Showed Positive Results for Rheumatoid Arthritis in Phase 2b Study
October 21, 2013
 · 
9 min read
Load More